These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 24148897)
1. Extracellular vesicles: small but strong. Martínez MC Cardiovasc Res; 2013 Dec; 100(3):350-1. PubMed ID: 24148897 [No Abstract] [Full Text] [Related]
2. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice. Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631 [TBL] [Abstract][Full Text] [Related]
3. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874 [TBL] [Abstract][Full Text] [Related]
4. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats. Ahmed LA; Rizk SM; El-Maraghy SA Biochem Pharmacol; 2017 Aug; 138():193-204. PubMed ID: 28450224 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. Spees JL; Whitney MJ; Sullivan DE; Lasky JA; Laboy M; Ylostalo J; Prockop DJ FASEB J; 2008 Apr; 22(4):1226-36. PubMed ID: 18032636 [TBL] [Abstract][Full Text] [Related]
6. Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor. Xiao R; Su Y; Feng T; Sun M; Liu B; Zhang J; Lu Y; Li J; Wang T; Zhu L; Hu Q J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28330842 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice. Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212 [TBL] [Abstract][Full Text] [Related]
9. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression. Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780 [TBL] [Abstract][Full Text] [Related]
12. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats. Wang Y; Zhang XH; Wang HL Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414 [TBL] [Abstract][Full Text] [Related]
13. Impaired mobilization of endothelial progenitor cells in acute lung injury/acute respiratory distress syndrome: inhibition of an endogenous mechanism of lung repair. McGuire JK Pediatr Crit Care Med; 2013 Jun; 14(5):555-6. PubMed ID: 23867440 [No Abstract] [Full Text] [Related]
14. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275 [TBL] [Abstract][Full Text] [Related]
15. Correlation of ionizing irradiation-induced late pulmonary fibrosis with long-term bone marrow culture fibroblast progenitor cell biology in mice homozygous deletion recombinant negative for endothelial cell adhesion molecules. Epperly MW; Guo H; Shields D; Zhang X; Greenberger JS In Vivo; 2004; 18(1):1-14. PubMed ID: 15011745 [TBL] [Abstract][Full Text] [Related]
16. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension. Zhao H; Xue Y; Guo Y; Sun Y; Liu D; Wang X Int Immunopharmacol; 2017 Jan; 42():115-121. PubMed ID: 27912147 [TBL] [Abstract][Full Text] [Related]
18. Emerging role of c-kit+ progenitor cells in pulmonary hypertension. Schwarz J Am J Respir Crit Care Med; 2011 Jul; 184(1):5-7. PubMed ID: 21737590 [No Abstract] [Full Text] [Related]
19. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension. Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990 [TBL] [Abstract][Full Text] [Related]
20. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]